Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.

Journal of thrombosis and thrombolysis - 1 Oct 2012

Bôžiková Alexandra, Gabriková Dana, Sovičová Adriana, Behulová Regina, Mačeková Soňa, Boroňová Iveta, Petrejčíková Eva, Soták Miroslav, Bernasovská Jarmila, Bernasovský Ivan

Abstract excerpt

Factor V Leiden and prothrombin G20210A are the two most prevalent causes of inherited thrombophilia. The prevalence of these mutations varies widely in healthy Caucasian population. The aim of our study was to determine the frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma ethnic group from Eastern Slovakia. We analyzed 540 asymptomatic individuals (269 individuals of Slovak...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Mutation, Missense

Share to Prothrombin

Share to Slovakia

Share to Thrombophilia

Source

Identifiers

PMID: 22562116
DOI: 10.1007/s11239-012-0736-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.PMID 22562116Read ↗

Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (Gypsy) populations.Semantic proximity Read ↗

Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.Semantic proximity Read ↗

Prothrombin gene 20210A mutation in Slovak population.Semantic proximity Read ↗

Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.Semantic proximity Read ↗

Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.Semantic proximity Read ↗

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.Semantic proximity Read ↗

Investigating the Matrix of Factor V Leiden (G1691A), Factor II Prothrombin (G2021A), MTHFR C677T and A1298G Polymorphisms in Greek Population: A Preliminary Study.Semantic proximity Read ↗

Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular DiseasesSemantic proximity Read ↗

Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.Semantic proximity Read ↗

Prevalence of prothrombotic polymorphisms in Greece.Semantic proximity Read ↗

Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism.Semantic proximity Read ↗

[Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.